Peripheral bypass graft occlusion

1. TET2 is associated with peripheral bypass graft occlusion in humans (HR 6.70 (95% CI 1.96-22.96)).

   Humansin patients with peripheral arterial disease who underwent femoropopliteal or femorocrural bypass graftingsomatic mutationperipheral bloodn = 47

   TET 2-mutant clonal hematopoiesis is associated with peripheral bypass graft occlusion: A multicenter retrospective cohort pilot study · JVS-vascular science · 23 Aug 2026

TET2 →